EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Single-dose intravenous α2-agonists do not acutely alter anti-inflammatory bioactive protein profiles but reduce interleukin-8 in equine autologous protein solution and platelet-rich plasma

Kara A Brown, Luma N F Max, Sarah E Struble, Renata L Linardi, Kyla F Ortved iD

American Journal of Veterinary Research · 2026

DOI: 10.2460/ajvr.26.02.0055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Kara A Brown und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Adrenergic alpha-2 Receptor Agonists, Imidazoles, Interleukin-8, Platelet-Rich Plasma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Determine the acute effects of xylazine and detomidine on concentrations of selected growth factors, cytokines, and α 2 -macroglobulin (A2M) in platelet-rich plasma (PRP) and autologous protein solution (APS) and the long-term effects of these sedatives on serum A2M. We hypothesized that sedative administration would decrease concentrations of all bioactive proteins in PRP and APS acutely and A2M in serum for 6 days following sedative administration.

Methods

6 horses were randomized to receive IV xylazine (200 mg) or detomidine (10 mg). Blood was collected before and 5 minutes after sedative administration for processing of PRP (Restigen PRP) and APS (Pro-Stride) and every 24 hours for 6 days. After a 2-week washout, horses were administered the other sedative, and blood was obtained in a crossover design. Platelet-rich plasma and APS were analyzed for concentrations of platelets, leukocytes, A2M, and selected growth factors and cytokines, and serum was analyzed for concentration of A2M.

Results

The IL-8 concentration decreased in PRP after xylazine administration. There were no other differences in the composition of APS or PRP after either sedative. Serum A2M concentration was unchanged for 6 days following sedative administration.

Conclusions

Intravenous xylazine decreased the concentration of one proinflammatory cytokine in PRP, with no effects on the composition of APS. Detomidine did not alter the composition of PRP or APS. The A2M concentrations were unchanged. Clinical Relevance Xylazine and detomidine do not alter the concentration of selected anti-inflammatory proteins in PRP and APS and are suitable for use 5 minutes before the collection of blood for processing at the doses administered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic alpha-2 Receptor AgonistsImidazolesInterleukin-8Platelet-Rich PlasmaXylazineAnimalsFemaleMalealpha-MacroglobulinsCross-Over StudiesCytokinesHorsesHypnotics and Sedatives

Stichwörter der Autor:innen

cytokineequinegrowth factororthobiologicsedative

Substanzen

Adrenergic alpha-2 Receptor Agonistsalpha-MacroglobulinsCytokinesdetomidineHypnotics and SedativesImidazolesInterleukin-8Xylazine

Autor:innen und Institutionen

ORCID-Profile: Kyla F Ortved

Zitieren

APA

Brown, K. A., Max, L. N. F., Struble, S. E., Linardi, R. L., & Ortved, K. F. (2026). Single-dose intravenous α2-agonists do not acutely alter anti-inflammatory bioactive protein profiles but reduce interleukin-8 in equine autologous protein solution and platelet-rich plasma. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.26.02.0055

Vancouver

Brown KA, Max LNF, Struble SE, Linardi RL, Ortved KF. Single-dose intravenous α2-agonists do not acutely alter anti-inflammatory bioactive protein profiles but reduce interleukin-8 in equine autologous protein solution and platelet-rich plasma. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.26.02.0055

BibTeX
@article{Brown2026,
  author = {Brown, Kara A and Max, Luma N F and Struble, Sarah E and Linardi, Renata L and Ortved, Kyla F},
  title = {Single-dose intravenous α2-agonists do not acutely alter anti-inflammatory bioactive protein profiles but reduce interleukin-8 in equine autologous protein solution and platelet-rich plasma},
  journal = {American Journal of Veterinary Research},
  year = {2026},
  doi = {10.2460/ajvr.26.02.0055}
}
Kostenlos starten →